Rare BRCA1 p.S1140Mfs*18 germline mutation in a family with breast and ovarian cancer
Two patients were enrolled at Hanzhong 3201 Hospital, Xi an Jiaotong University (Shaanxi, China) between May 2024 and January 2025, and peripheral blood samples were analyzed by next-generation sequencing (NGS) and Sanger sequencing.